60 related articles for article (PubMed ID: 8963493)
1. [Interleukin-6 and acute phase reactants in the diagnosis of ovarian carcinoma].
Svoboda B; Kanka J; Folauf V; Svárovský J; Kaspárková H; Musil J; Nováková O; Dvoráková M; Dyrynková V
Ceska Gynekol; 1996 Aug; 61(4):234-9. PubMed ID: 8963493
[TBL] [Abstract][Full Text] [Related]
2. [Changes of serum il-6 and CRP after chemotherapy in patients with ovarian carcinoma].
Zakrzewska I; Poznański J
Pol Merkur Lekarski; 2001 Sep; 11(63):210-3. PubMed ID: 11761812
[TBL] [Abstract][Full Text] [Related]
3. [Lysophosphatidic acid in ovarian cancer patients].
Sedlákova I; Vávrová J; Tosner J; Hanousek L
Ceska Gynekol; 2006 Jul; 71(4):312-7. PubMed ID: 16956044
[TBL] [Abstract][Full Text] [Related]
4. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin 6 (IL-6)--a biological marker in patients with ovarian cancer?].
Schröder W; Ruppert C; Bender HG
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():200-1. PubMed ID: 8118269
[No Abstract] [Full Text] [Related]
6. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
Menczer J; Ben-Baruch G; Moran O; Lipitz S
Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of GRP78 is associated with malignant transformation in epithelial ovarian tumors.
Huang LW; Lin CY; Lee CC; Liu TZ; Jeng CJ
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):381-5. PubMed ID: 22495374
[TBL] [Abstract][Full Text] [Related]
8. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
Miladinović D; Paunović R; Paunković N
Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
[TBL] [Abstract][Full Text] [Related]
9. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
10. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
11. [The value of CA125 and LDH assays in assisting diagnosis of epithelial ovarian carcinoma].
Qie M; Peng Z; Cao Z; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):310-3. PubMed ID: 9389070
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum VEGF in women with ovarian tumors.
Oehler MK; Caffier H
Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
[TBL] [Abstract][Full Text] [Related]
14. Serum tetranectin in patients with acute pelvic inflammatory disease (PID). Correlation to clinical and laboratory findings.
Høgdall CK; Christiansen M; Brihmer C
Acta Obstet Gynecol Scand; 1995 Mar; 74(3):203-7. PubMed ID: 7534970
[TBL] [Abstract][Full Text] [Related]
15. Thymic carcinoma associated with a high serum level of interleukin 6 diagnosed through the evaluation for asymptomatic elevation of acute-phase reactants.
Ikeda T; Kawakami K; Fujita J; Bandoh S; Yamadori I; Takahara J
Intern Med; 1998 Apr; 37(4):414-6. PubMed ID: 9630206
[TBL] [Abstract][Full Text] [Related]
16. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
[TBL] [Abstract][Full Text] [Related]
17. Role of osteopontin in differential diagnosis of ovarian tumors.
Moszynski R; Szubert S; Szpurek D; Michalak S; Sajdak S
J Obstet Gynaecol Res; 2013 Nov; 39(11):1518-25. PubMed ID: 23875677
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
20. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
